Somatic Gene Therapy: Methods for the Present and Future

Archives of Otolaryngology--Head and Neck Surgery

Volumn 119, Issue 10, 1993, Pages 1100-1107

  O'malley, Bert W ^a   Ledley, Fred D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; BLOOD CLOTTING FACTOR 8; CYTOKINE; DNA; GENE PRODUCT; HLA B7 ANTIGEN; HORMONE; LIPOPROTEIN; RNA; TUMOR NECROSIS FACTOR;

ADENOVIRUS; AUTOTRANSPLANTATION; ETHICS; GENE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GENETIC RECOMBINATION; GERM CELL; HALF LIFE TIME; HEMOPHILIA; HERPES VIRUS; HUMAN; MELANOMA; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; RECOMBINANT GENE; RETROVIRUS; REVIEW; SOMATIC CELL; VIRUS RECOMBINANT;

CLINICAL TRIALS; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; HUMAN; OTOLARYNGOLOGY; SUPPORT, NON-U.S. GOV'T;

EID: 0027423781     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archotol.1993.01880220044007     Document Type: Article

References (38)

1. Miller AD. Human gene therapy comes of age. Nature. 1992;357:455-460.
2. Anderson WF. Human gene therapy. Science. 1992;256:808-813.
3. Ledley FD. Are contemporary methods for somatic gene therapy suitable for clinical applications? Clin Invest Med. 1993;16:78-88.
4. O'Malley BW Jr, Ledley FD. Somatic gene therapy in otolaryngology—head and neck surgery. Arch Otolaryngol Head Neck Surg. In press.
5. Rosenberg SA. Gene therapy for cancer. JAMA. 1992;268:2416-2419.
6. Human Gene Therapy: Background Paper. Washington, DC: Office of Technology Assessment; 1984.
7. Recombinant DNA Advisory Committee. Points to consider in the design and submission of human somatic cell gene therapy protocols. Federal Register. 1990;54:36698-36703.
8. Reprinted in: Hum Gene Ther. 1990;1:93-103.
9. Vega MA. Prospects for ‘homologous recombination’ in human gene therapy. Hum Genet. 1991;87:245-253.
10. Capecchi MR. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell. 1980;22:479-488.
11. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465-1468.
12. Feigner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A. 1987;84:7413-7417.
13. Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci U S A. 1992;89:7934-7938.
14. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem. 1987;262:4429-4432.
15. Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A. 1990;87:9568-9572.
16. Curiel DT, Agarwal S, Wagner E, Cotten M. Adenovirus enhancement of transferrinpolylysine-mediated gene delivery. Proc Natl Acad Sci U S A. 1991;88:8850-8854.
17. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci U S A. 1990;87:3410-3414.
18. Miller AD. Retrovirus packaging cells. Hum Gene Ther. 1990;61:5-14.
19. Ledley FD. Human gene therapy. In: Jacobson GK, Jolly SO, eds: Biotechnology. A Comprehensive Treatise. Weinheim, Germany: VCH Verlagsgesellschaft. 1989;7b:399-461.
20. Cornetta K, Morgan RA, Anderson WF. Safety issues related to retroviral mediated gene transfer in humans. Hum Gene Ther. 1991;2:5-14.
21. Cornetta K, Moen RC, Culver K, et al. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Hum Gene Ther. 1990;1:15-30.
22. Berkner KL. Development of adenovirus vectors for the expression of heterologous genes. Bio Techniques. 1988;6:616-629.
23. Geller Al, Keyomarsi K, Bryan J, Pardee AB. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci U S A. 1990;87:8950-8954.
24. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adenoassociated viruses: normal integration does not require viral gene expression. J Virol. 1989;63:3822-3828.
25. Ledley FD, Adams RM, Soriano HE, et al. Development of a clinical protocol for hepatic gene transfer: lessons learned in pre-clinical studies. Pediatr Res. 1993; 33:313-320.
26. O'Malley BW Jr, Finegold MJ, Ledley FD. Autologous, orthotopic thyroid follicular cell transplantation: a surgical component of ex vivo somatic gene therapy. Otolaryngol Head Neck Surg. 1993;108:51-62.
27. Ban E, Leiden JM. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science. 1991;254:1507-1509.
28. Scharfmann R, Axelrod JH, Verman IM. Long-term in vivo expression of retrovirusmediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci U S A. 1991;88:4676-4680.
29. Mastrogeli A, Pavirani A, Lecocq JP, Crystal RG. Diversity or airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene therapy. J Clin Invest 1993;91:225-234.
30. Stratford-Perricaudet LD, Levrero M, Chasse JF, Perricaudet M, Briand P. Evaluation of the transfer and expression in mice of an enzyme encoding gene using a human adenovirus vector. Hum Gene Ther. 1990;1:241-256.
31. Stratford-Perricaudet LD, Makeh I, Perricaudet M. Briand P. Widespread longterm gene transfer to mouse skeletal muscles and heart. J Clin Invest. 1992; 90:626-630.
32. Fletcher JC. Evolution of ethical debate about human gene therapy. Hum Gene Ther. 1990;1:55-68.
33. Anderson WF, Fletcher JC. Gene therapy in human beings: when is it ethical to begin? N Engl J Med. 1980;303:1293-1297.
34. Surgeon General. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research: Splicing Life. Washington DC: US Dept of Health and Human Services; 1983.
35. Ledley FD. Clinical considerations in the design of protocols for somatic gene therapy. Hum Gene Ther. 1991;2:77-84.
36. Ledley FD, Brody B, Kozinetz C, Mize M. The challenge of follow-up for clinical trials of somatic gene therapy. Hum Gene Ther. 1991;2:657-664.
37. Ledley FD. The application of gene therapy to pediatric practice. Int Pediatr. 1992;7:7-15.
38. Rosenberg, SA, Aebersold P, Cornetta K, et al. Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med. 1990; 323:570-578.